Automated Endoscope Reprocessors (AER) segment has been significantly growing with the high risk of infection during endoscopy surgeries.
Rising cases of endoscopy-related infections and a growing number of diseases requiring endoscopy procedures are some factors driving the market growth. Endoscopy procedures are a cost-efficient, effective, and safer option than traditional open surgeries. Endoscopy procedures are covered by health insurance providers in developed countries such as the US, Canada, and others. It is increasingly being used to diagnose or treat various major disorders, such as cancer, orthopaedic, and neurological disorders. These factors have led to a high preference of endoscopy procedures among patients and physicians. Moreover, the automated endoscope reprocessors segment is expected to grow tremendeously, as during COVID-19 pandemic the sterilization became utmost priority, the importance of automated endoscope reprocessors has grown and become an essential part of the preparations for conducting endoscopic surgeries. In addition, AER has been increasingly adopted in hospitals and clinics, and there is rising demand for them owing to their benefits.
Within the report, the market is segmented into product, end user, and geography. By product, the market is further segmented into high-level disinfectants and test strips, detergents and wipes, endoscope drying, storage and transport systems, endoscope tracking systems, automated endoscope reprocessors (AER), and other products. Based on end user, the market is divided into hospitals, ambulatory surgical centers, and other end users. Geographically, the market is sub segmented into North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa.
North America is expected to hold largest market share during the forecast period.
Endoscope reprocessing is the process of sterilizing, disinfecting, and cleaning of endoscopic equipment. Equipment reprocessing is performed to prevent transfer of any microbes or infection from one patient to another during reusage of the equipment. Across the North America region, community-based ambulatory endoscopy centers are reopening and safely resuming outpatient endoscopic procedures, and the guidelines recommend reprocessing, pre-testing, and screening for COVID-19, along with other mitigation measures, for the safety of patients and staff. In addition, owing to the rising prevalence of diseases requiring endoscopy procedures and better healthcare infrastructure, the region will witness a larger share.
Rising adoption of devices in hospitals is accelerating the market growth.
Hospitals accounted for the highest market share owing to high use of endoscopic devices in hospitals facility to perform an increased number of endoscopic procedures compared to other healthcare settings. Thus, the demand for these systems is likely to grow in hospitals. In addition, the devices are also used for diagnosis and treatment due to the rising burden of various digestive and respiratory tract disorders that require endoscopy. Frequent use of these endoscopic instruments result in an increased risk of infections; hence, these are disinfected and cleaned using reprocessing systems.
Recent strategic developments in endoscope reprocessing market
The endoscope reprocessing market has undergone several significant developments, and a few of these have been mentioned below:
The endoscope reprocessing market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Getinge, Olympus, STERIS, Ecolab, Wassenburg Medical, Steelco, and ENDO-TECHNIK GmbH are among the prominent players operating in the market.
Target audience for the report:
Scope of the report:
In this report, the market has been segmented on the basis of:
Companies profiled:
- Getinge
- Olympus
- STERIS
- Ecolab
- Wassenburg Medical
- Steelco
- ENDO-TECHNIK GmbH
- Fortive Corporation
- Custom Ultrasonics
- Advanced Sterilization Products (ASP)